| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Pharmesis International Ltd (SG: BFK)
BFK Technical Analysis
5
| As on 18th Nov 2024 BFK STOCK Price closed @ 0.64 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.11 & Strong Buy for SHORT-TERM with Stoploss of 0.13 we also expect STOCK to react on Following IMPORTANT LEVELS. |
BFKSTOCK Price
| Open | 0.64 | Change | Price | % |
| High | 0.64 | 1 Day | 0.02 | 3.23 |
| Low | 0.64 | 1 Week | 0.01 | 1.59 |
| Close | 0.64 | 1 Month | 0.31 | 93.94 |
| Volume | 1000 | 1 Year | 0.53 | 481.82 |
| 52 Week High 0.63 | 52 Week Low 0.08 | ||||
SG Singapore Most Active Stocks
| S51 | 1.39 | -5.44% |
| 579 | 0.01 | % |
| G13 | 0.76 | -2.56% |
| C38U | 1.93 | -0.52% |
| Z74 | 3.06 | -2.24% |
| Y92 | 0.52 | 0.00% |
| BS6 | 2.67 | 0.75% |
| M44U | 1.26 | 0.80% |
| K71U | 0.85 | -1.16% |
| FQ7 | 0.00 | % |
SG Singapore Top Gainers Stocks
SG Singapore Top Losers Stocks
| BFK Daily Charts |
BFK Intraday Charts |
Whats New @ Bazaartrend |
BFK Free Analysis |
|
|
BFK Important Levels Intraday
| RESISTANCE | 0.64 |
| RESISTANCE | 0.64 |
| RESISTANCE | 0.64 |
| RESISTANCE | 0.64 |
| RESISTANCE | 0.64 |
| RESISTANCE | 0.64 |
| RESISTANCE | 0.64 |
| RESISTANCE | 0.64 |
BFK Forecast November 2024
| 4th UP Forecast | 0.68 |
| 3rd UP Forecast | 0.67 |
| 2nd UP Forecast | 0.66 |
| 1st UP Forecast | 0.65 |
| 1st DOWN Forecast | 0.63 |
| 2nd DOWN Forecast | 0.62 |
| 3rd DOWN Forecast | 0.61 |
| 4th DOWN Forecast | 0.6 |
BFK Weekly Forecast
| 4th UP Forecast | 0.66 |
| 3rd UP Forecast | 0.65 |
| 2nd UP Forecast | 0.65 |
| 1st UP Forecast | 0.65 |
| 1st DOWN Forecast | 0.63 |
| 2nd DOWN Forecast | 0.63 |
| 3rd DOWN Forecast | 0.63 |
| 4th DOWN Forecast | 0.62 |
BFK Forecast2024
| 4th UP Forecast | 1.83 |
| 3rd UP Forecast | 1.45 |
| 2nd UP Forecast | 1.21 |
| 1st UP Forecast | 0.98 |
| 1st DOWN Forecast | 0.3 |
| 2nd DOWN Forecast | 0.07 |
| 3rd DOWN Forecast | -0.17 |
| 4th DOWN Forecast | -0.55 |
Pharmesis International Ltd ( SG Singapore Symbol : BFK )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
BFK Business Profile
Pharmesis International Ltd., an investment holding company, researches, develops, produces, packages, sells, and markets western medicines and traditional Chinese medicine (TCM) formulated products for hospitals and medical institutions in the People's Republic of China. The company provides prescribed products and over-the-counter drugs. It offers western medicine products under the brand name of Kinna, including Anethole Trithione for the treatment of illness relating to the liver and gall bladder; Compound Procaine hydrochloride to treat arteriosclerosi, menopausal symptoms, dyspepsia, and adynamia; Lianpushuangqing for acute inflammation; AFenKa to treat migraine, pain, headache, nasosinusitis, cold, muscle pain, menstrual pain, toothache, and arthritis; Xiao Shi Jian Pi to treat flatus, inappetency, dyspepsy, and spleen weakness; and Xiao Luo Tong for the rheumatoid arthritis and other rheumatic diseases treatment. The company also provides TCM formulated products under the Longlife brand name comprising Gulin Gansu for acute and chronic hepatitis treatment; Er Ding granules to treat jaundice, and clear heat and toxics; and Kang Gu Zeng Sheng for boosting the functions of kidney, as well as for increasing blood circulation and alleviating pain. In addition, it offers health supplement products, such as Mei Li Wei Ta to combat aging process and support bone health for women; Hao Xiu Xi to enhance sleep and regulate blood fats; Hao Zhuang Tai to regulate blood fats and fight fatique; and Qianlieman'an for promoting healthy prostate function and colon health, and supporting urinary function, as well as SHULINGHOU for the treatment of acute and chronic pharyngitis, laryngitis, sore throat, and hoarseness. Further, the company engages in the wholesale of chemical drugs, biological raw products, TCM products, antibiotics, and antibiotic agents. Pharmesis International Ltd. was founded in 1996 and is based in Singapore. Address: No. 03-02, 5 Kallang Sector, Singapore, Singapore, 349279
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service